Medexus Pharmaceuticals Inc. (MEDXF)
OTCMKTS
· Delayed Price · Currency is USD
1.990
-0.100 (-4.78%)
Feb 21, 2025, 3:52 PM EST
Medexus Pharmaceuticals Employees
Medexus Pharmaceuticals had 82 employees as of March 31, 2024. The number of employees decreased by 16 or -16.33% compared to the previous year.
Employees
82
Change (1Y)
-16
Growth (1Y)
-16.33%
Revenue / Employee
$1,335,854
Profits / Employee
$43,439
Market Cap
65.17M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Endo Inc. | 2,931 |
| Elite Pharmaceuticals | 64 |
| Glass House Brands | 413 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 9 |
| Silence Therapeutics | 109 |
| SANUWAVE Health | 31 |
Medexus Pharmaceuticals News
- 16 days ago - Medexus Pharmaceuticals, Inc. (MEDXF) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 17 days ago - Medexus Announces Strong Fiscal Q3 2025 Results, Well-Positioned to Launch GRAFAPEX (treosulfan) for Injection in the United States - Newsfile Corp
- 19 days ago - Medexus and Ontario's Provincial Health Services Successfully Complete Agreements for Public Reimbursement of Trecondyv (treosulfan for injection) in Ontario, Canada - Newsfile Corp
- 22 days ago - Medexus Schedules Third Fiscal Quarter 2025 Conference Call - Newsfile Corp
- 23 days ago - Medexus Pharmaceuticals Announces Closing of $30 Million Overnight Marketed Public Offering of Common Shares - Newsfile Corp
- 25 days ago - Medexus Pharmaceuticals Announces Pricing of $30 Million Overnight Marketed Public Offering of Common Shares - GlobeNewsWire
- 26 days ago - Medexus Pharmaceuticals Announces Overnight Marketed Public Offering of Common Shares - GlobeNewsWire
- 4 weeks ago - Medexus Announces FDA Approval of GRAFAPEX (treosulfan) for Injection and Provides Business Update - Newsfile Corp